Demand for antibody discovery tech set to keep growing

Increasing interest in targeted therapies is driving demand in the antibody discovery market, finds industry analyst Future Market Insights.

In a research note, the group stated that the value of the market, currently worth about $8.5 billion, is expected to grow at a compound annual growth rate of 9.9% over the next decade. This would put the global market valuation at $21.8 billion by 2034.

There are a range of reasons for the strong growth outlook,…

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

• All the news that moves the needle in pharma and biotech.• Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.• Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

• Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.• Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.• Daily roundup of key events in pharma and biotech.• Monthly in-depth briefings on Boardroom appointments and M&A news.• Choose from a cost-effective annual package or a flexible monthly subscription.